Atanda Adebayo C, Olafiranye Oladipupo
Department of Medicine, Howard University Hospital, Washington, DC.
Heart and Vascular Institute, Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Cardiovasc Revasc Med. 2017 Oct-Nov;18(7):549-553. doi: 10.1016/j.carrev.2017.06.001. Epub 2017 Jun 6.
Contrast-induced acute kidney injury (CI-AKI) is a common complication of many diagnostic and therapeutic cardiovascular procedures. It is associated with longer in-hospital stay, more complicated hospitalization course, and higher in-hospital morbidity and mortality. With increasing use of contrast media in various diagnostic and interventional procedures, the prevalence of CI-AKI is expected to rise. Although pre-hydration with intravenous normal saline is recommended in patients with elevated risk of CI-AKI, this approach is often not feasible in many clinical settings. Remote ischemic conditioning (RIC), elicited by application of one or more, brief, non-injurious episodes of ischemia and reperfusion of a limb, is a promising therapy for preventing or attenuating the deleterious effects of contrast media on the kidney. Although the mechanisms of protection by RIC have not been completely defined, complex humoral, neural, and inflammatory pathways have been hypothesized to be in play. Given that RIC is non-invasive and cheap, it is attractive from clinical and economic perspective as a therapy to protect the kidney from CI-AKI. In this succinct review, we highlight the unifying mechanisms of CI-AKI and provide an overview of proposed biological mechanisms of renal protection by RIC. Emerging pre-clinical and clinical evidence in interventional cardiology is also discussed.
对比剂诱导的急性肾损伤(CI-AKI)是许多诊断性和治疗性心血管手术常见的并发症。它与住院时间延长、住院过程更复杂以及更高的院内发病率和死亡率相关。随着造影剂在各种诊断和介入手术中的使用增加,CI-AKI的患病率预计会上升。尽管对于CI-AKI风险升高的患者建议静脉输注生理盐水进行预水化,但在许多临床环境中这种方法往往不可行。远程缺血预处理(RIC)通过对肢体施加一次或多次短暂、无害的缺血和再灌注发作来引发,是一种预防或减轻造影剂对肾脏有害影响的有前景的治疗方法。尽管RIC的保护机制尚未完全明确,但推测复杂的体液、神经和炎症途径发挥了作用。鉴于RIC是非侵入性且成本低廉的,从临床和经济角度来看,它作为一种保护肾脏免受CI-AKI影响的治疗方法具有吸引力。在这篇简短的综述中,我们强调了CI-AKI的统一机制,并概述了RIC肾脏保护作用所提出的生物学机制。还讨论了介入心脏病学中新兴的临床前和临床证据。